ITM Power: After the MSCI Hangover, Three Binary Catalysts Hold the Key

The timing was almost scripted. ITM Power’s shares hit a 52-week high of 219.80 pence in late May, only to shed seven percent on the very day the stock joined the MSCI United Kingdom Small Cap Index. Volume surged to 27.6 million shares — more than four times the daily average — as a classic “buy the rumour, sell the fact” pattern played out. The stock closed at 194.40 pence and has since drifted to 188.70 pence, but the real drama is only just beginning.

That post-index pullback masks what could be a transformative month for the British electrolyser maker. June brings three make-or-break catalysts, any one of which could send the shares sharply higher or lower. The first — and arguably most critical — is the regulatory clearance for a £46.5 million government grant. The Competition and Markets Authority completed its state-aid review on 20 May, unlocking the funding from the Department for Energy Security and Net Zero. The money, spread across the 2026/27 and 2027/28 fiscal years, is earmarked for the Chronos automated production line in Sheffield.

Chronos is the technological heart of the investment case. The new 2 MW unit delivers triple the output of the existing Trident platform, slashes production costs by 40 percent and halves the factory footprint. Up to 90 percent of components are recyclable. ITM is investing £120 million in the Sheffield site to build out a 1 GW capacity by 2028. The grant approval has already lifted the year-end liquidity forecast from £170-175 million to £210-215 million. Great British Energy, meanwhile, holds nearly 72 million new shares after a £40 million direct investment, making it the second-largest shareholder.

The second catalyst is the second British hydrogen allocation round, known as HAR2. The government is awarding 875 MW of capacity from a pool of 87 applications totalling 2.8 GW — 27 projects have been shortlisted. ITM Power is the contracted electrolyser supplier for Uniper’s Humber H2ub project, with six 20 MW Poseidon modules scheduled for commissioning by 2029. A successful HAR2 award to that project would meaningfully boost ITM’s current order book of £152 million, of which 71 percent of contracts are now considered profitable.

Should investors sell immediately? Or is it worth buying ITM Power?

That feeds directly into the third binary event: Uniper’s final investment decision for the 120 MW Killingholme project. The front-end engineering and design contract was signed in June 2025, planning permission was secured in March 2026, and the FID is expected this year. Separately, ITM’s flagship REFHYNE-2 project — a 100 MW electrolyser at Shell’s Energy and Chemicals Park in Rheinland — won two prizes at the 2026 World Hydrogen Awards in Rotterdam. From 2027 it is expected to produce up to 44,000 kilograms of renewable hydrogen daily.

The numbers are improving, albeit slowly. For the financial year ending 2026, ITM forecasts revenue of £40-43 million, an increase of around 35 percent. The first half already set a record at £18 million. The adjusted EBITDA deficit narrowed from £16.8 million to £11.9 million, though the full-year loss is expected to land between £27 million and £29 million. The pre-tax loss widened to £45.4 million. On the balance sheet, nearly £200 million in cash and zero debt give the company breathing room — analysts see no need for a capital raise this decade.

Analyst sentiment is turning more constructive. Jefferies lifted its price target to 200 pence from 115 pence. Morgan Stanley upgraded the stock to Overweight — the first positive rating for a UK hydrogen name since 2021. Berenberg retains a Buy but with a much lower target of 110 pence, while UBS remains Neutral at 60 pence. Of the twelve analysts covering ITM, seven recommend buying. The consensus view is that EBITDA breakeven could arrive in fiscal 2028, a year earlier than previously forecast — provided the company books roughly 200 MW of new orders.

ITM Power at a turning point? This analysis reveals what investors need to know now.

All three June decisions — the CMA green light for Chronos, the HAR2 outcome, and Uniper’s FID — should be resolved before ITM Power publishes its full-year results on 15 September 2026. By then the market will have a much clearer picture of whether the turnround has real substance. The MSCI hangover may prove a footnote if the next few weeks deliver the catalysts the stock so badly needs.

Ad

ITM Power Stock: New Analysis - 3 June

Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ITM Power analysis...

en | GB00B0130H42 | ITM | boerse | 69474928 |